Albumex-20 is a medicine containing the active ingredient(s) albumin human. On this page you will find out more about Albumex-20, including side effects, age restrictions, food interactions and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS)
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.
Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.
Active ingredient in this medicine: albumin human
Pack size information
Please select the pack size from the options directly below to view information on the medicine.
Information for medicine and pack size:
Albumex-20 20 g/100 mL intravenous infusion injection, 100 mL vial
Consumer Medicine Information leaflet:
This leaflet may also be found inside the medicine package. It contains information on side effects, age restrictions and other useful data.
What this medicine is for
INDICATIONS AS AT 27 JANUARY 2000: Hypoproteinaemia in the acutely ill patient: Albumex 20 is administered when there are existing or anticipated clinical problems or complications from reduced oncotic pressure, and/or as an adjunct to diuretic therapy. Shock: Albumex 20 may be used for the resuscitation of patients in shock due to acute loss of blood or plasma, but 4-5% human albumin is preferred when available. Burns: Extensive burns are followed by sequential shifts in the distribution of body water, salt and proteins, resulting in hypovolaemic shock and circulatory failure. Inititally (during the first 24 hours) there is an increased vascular permeability leading to loss of water and proteins into the extravascular compartment, and haemoconcentration. Large volumes of crystalloid solutions should be infused to restore the constricted intravascular fluid space, and smaller amounts of Albumex 20 are required to maintain adequate plasma volume and colloid osmotic pressure. Adult respiratory distress syndrome: The clinical syndrome is characterised by inadequate oxygenation secondary to pulmonary interstitial oedema, complicating shock and postoperative states resulting in a decreased central venous pressure, decreased plasma albumin concentration, rising blood pressure, reduced cardiac output, lowered pulse rate and falling renal output. The acute condition can be controlled by diuretics and Albumex 20 in amounts sufficient to maintain vital signs. In patients who have undergone abdominal surgery, the intravenous administration of albumin solution (20%) immediately after the operation has been shown to improve lung compliance and gaseous exchange. Haemodialysis: Albumex 20 may be used to assist with the rapid removal of excess extravascular fluid and to maintain perfusion pressure. Therapeutic plasma exchange: Therapeutic plasma exchange is a procedure in which approximately one plasma volume is exchanged with a colloid replacement solution. The choice of replacement fluid and its concentration are determined by the particular clinical situation and the frequency of the procedure. Iso-oncotic albumin solution is the preferred replacement material. If the patient's serum albumin level is not maintained, concentrated albumin (20%) may be indicated. If exchange occurs less frequently than once a week, less concentrated colloids may be appropriate.,Albumex 20 is indicated for hypoproteinaemia in the acutely ill patient, shock, plasma exchange, acute respiratory distress syndrome, haemodialysis and burns.
Table of characteristics
|Visual appearance||A clear, slightly viscous liquid; it is almost colourless, yellow, amber or green.|
|Dosage Form||Injection, intravenous infusion|
|Route of administration||Intravenous|
There is one type of pack available.
Pack type 1
|Storage temperature||Store below 30 degrees Celsius|
|Storage conditions||Do not Freeze,Protect from Light|
|Life time||4 Years|
We were unable to verify that this medicine is available on the PBS (Pharmaceutical Benefits Scheme). Please consult your pharmacist if you need further information
The PBS provides a list of government subsidised medicines available to be dispensed to patients. Further information can be found on the Pharmaceutical Benefits Scheme website.
Is this medication banned in sport?
Check if you can use your medicine whilst playing sport. Search the Australian Sports Anti-Doping Authority (ASADA) database that provides information about the prohibited status of specific medications and/or the active ingredient based on the current World Anti-Doping Agency (WADA) Prohibited List.